Price
No data yet.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Social Signal Score
Earnings
Typical surprise +32.1% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Feb 16$0.77 vs $0.94miss
- Wed, Nov 10$0.79 vs $0.70beat
- Wed, Aug 4$0.63 vs $0.60beat
- Wed, May 5$0.61 vs $0.35beat
- Wed, Feb 10$0.56 vs $0.37beat
- Wed, Oct 28$0.48 vs $0.31beat
Estimates and results for FLOW via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by FLOW officers and directors.
No open-market trades in the recent filings. All 100 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
100 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Valuation
FLOWhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsglobenewswire.com·6h ago·Neutral
Smith+Nephew's new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a breakthrough in RF resection technology for hip with its new FLOW FLEXTEND COBLATION Wand. Designed as an extension of its proprietary FLOW~IQ◊ technology with an adjustable-angle tip, the FLOW FLEXTEND Wand is designed to give surgeons enhanced joint access1 * a…
View source ↗